Journal article
HORYZONS trial: protocol for a randomised controlled trial of a moderated online social therapy to maintain treatment effects from first-episode psychosis services
Mario Alvarez-Jimenez, Sarah Bendall, Peter Koval, Simon Rice, Daniela Cagliarini, Lee Valentine, Simon D'Alfonso, Christopher Miles, Penni Russon, David L Penn, Jess Phillips, Reeva Lederman, Greg Wadley, Eoin Killackey, Olga Santesteban-Echarri, Cathrine Mihalopoulos, Helen Herrman, Cesar Gonzalez-Blanch, Tamsyn Gilbertson, Shalini Lal Show all
BMJ OPEN | BMJ PUBLISHING GROUP | Published : 2019
Abstract
INTRODUCTION: Specialised early intervention services have demonstrated improved outcomes in first-episode psychosis (FEP); however, clinical gains may not be sustained after patients are transferred to regular care. Moreover, many patients with FEP remain socially isolated with poor functional outcomes. To address this, our multidisciplinary team has developed a moderated online social media therapy (HORYZONS) designed to enhance social functioning and maintain clinical gains from specialist FEP services. HORYZONS merges: (1) peer-to-peer social networking; (2) tailored therapeutic interventions; (3) expert and peer-moderation; and (4) new models of psychological therapy (strengths and mind..
View full abstractGrants
Awarded by Mental Illness Research Fund from the State Government of Victoria
Awarded by National Health and Medical Research Council (NHMRC)
Awarded by NHMRC
Awarded by NHMRC Early Career Fellowship
Funding Acknowledgements
The HORYZONS trial was supported by the Mental Illness Research Fund from the State Government of Victoria. MA-J was supported by a Career Development Fellowship (APP1082934) from the National Health and Medical Research Council (NHMRC). SMC has been supported by a Career Development Fellowship (APP1061998) and Senior Research Fellowship (APP1136344) from NHMRC. ChM was supported by a NHMRC Early Career Fellowship (APP1035887) during the conduct of the trial. SL was supported in part by a New Investigator Salary Award from the Canadian Institutes of Health Research and previously in part by a Research Scholar Salary Award from the Fonds de recherche du Quebec-Sante.